BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/22/2021 10:34:52 AM | Browse: 424 | Download: 1046
 |
Received |
|
2021-04-28 20:21 |
|
Peer-Review Started |
|
2021-04-28 20:24 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-24 12:07 |
|
Revised |
|
2021-07-23 10:36 |
|
Second Decision |
|
2021-10-13 06:20 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-10-14 02:44 |
|
Articles in Press |
|
2021-10-14 02:44 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-11-15 06:15 |
|
Publish the Manuscript Online |
|
2021-11-22 10:34 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Did the severe acute respiratory syndrome-coronavirus 2 pandemic cause an endemic Clostridium difficile infection?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Camelia Cojocariu, Irina Girleanu, Anca Trifan, Andrei Olteanu, Cristina Maria Muzica, Laura Huiban, Stefan Chiriac, Ana Maria Singeap, Tudor Cuciureanu, Catalin Sfarti and Carol Stanciu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Anca Trifan, FRCP, MD, Teacher, Department of Gastroenterology, “Grigore T. Popa” University of Medicine and Pharmacy, “St. Spiridon” University Hospital, Institute of Gastroenterology and Hepatology, Str. Universității no 16, Iasi 700115, Romania. ancatrifan@yahoo.com |
| Key Words |
COVID-19 infection; Clostridium difficile infection; Risk factors; Antibiotic use; Pandemic; Recurrence |
| Core Tip |
The coronavirus disease 2019 (COVID-19) pandemic was associated with an increased prevalence of Clostridium difficile infections. Previous hospitalization and antibiotic treatment are known risk factors for Clostridium difficile infection. Patients with a past history of COVID-19 infection, however, required higher doses of vancomycin and were more prone to developing recurrent disease. Rational antibiotic use should be implemented in all patients with COVID-19 infection. Diarrhea is a symptom of COVID-19 infection, which could delay the diagnosis of Clostridium difficile infection. All the patients should be tested for Clostridium difficile toxins A and B if watery diarrhea develops. |
| Publish Date |
2021-11-22 10:34 |
| Citation |
Cojocariu C, Girleanu I, Trifan A, Olteanu A, Muzica CM, Huiban L, Chiriac S, Singeap AM, Cuciureanu T, Sfarti C, Stanciu C. Did the severe acute respiratory syndrome-coronavirus 2 pandemic cause an endemic Clostridium difficile infection? World J Clin Cases 2021; 9(33): 10180-10188 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i33/10180.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i33.10180 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
